Erwin J. Robles-Pinillos

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Corrigendum to "Mortality predictors in pulmonary sarcoidosis: results from the Spanish cohort SARCO-I" [Respir. Med. 251 (2026) 108591].

Corrigendum to "Mortality predictors in pulmonary sarcoidosis: results from the Spanish cohort SARCO-I" [Respir. Med. 251 (2026) 108591].

Journal: Respiratory medicine
Published: August 28, 2026

Mortality predictors in pulmonary sarcoidosis: results from the Spanish cohort SARCO-I.

Mortality predictors in pulmonary sarcoidosis: results from the Spanish cohort SARCO-I.

Journal: Respiratory medicine
Published: July 09, 2025

Single-cell RNA sequencing of human blood eosinophils reveals plasticity and absence of canonical cell subsets.

Single-cell RNA sequencing of human blood eosinophils reveals plasticity and absence of canonical cell subsets.

Journal: Allergy
Published: April 29, 2024

Benralizumab reduces blood basophil percentage and activation in vitro without eliciting degranulation.

Benralizumab reduces blood basophil percentage and activation in vitro without eliciting degranulation.

Journal: Allergy
Published: March 07, 2024

Moderate-High Blood Eosinophilia Is Associated with Increased Hospitalization and Other Asthma Comorbidities.

Moderate-High Blood Eosinophilia Is Associated with Increased Hospitalization and Other Asthma Comorbidities.

Journal: Biomolecules
Published: November 20, 2023

Long-term immune response accompanies clinical outcomes in severe asthmatics treated with anti-IL-5/IL-5R biologics.

Long-term immune response accompanies clinical outcomes in severe asthmatics treated with anti-IL-5/IL-5R biologics.

Journal: Allergy
Published: June 12, 2023

Impact of COVID-19 Infection on Patients with Preexisting Interstitial Lung Disease: A Spanish Multicentre Study.

Impact of COVID-19 Infection on Patients with Preexisting Interstitial Lung Disease: A Spanish Multicentre Study.

Journal: Archivos de bronconeumologia
Published: November 27, 2022

Serum microRNAs as Tool to Predict Early Response to Benralizumab in Severe Eosinophilic Asthma.

Serum microRNAs as Tool to Predict Early Response to Benralizumab in Severe Eosinophilic Asthma.

Journal: Journal of personalized medicine
Published: December 28, 2020
Showing 1-8 of 8

Last Updated: 09/26/2026